Autorisation d’accès précoce refusée à la spécialité ZURZUVAE (zuranolone) dans l'indication « traitement de la dépression sévère du post-partum (DPP) suivant l’accouchement chez les adultes. »
See also
HAS opinions and decisions
23/06/2025
eNrFmF1v2jAUhu/5FVHuk/BZYApUG2s3pFZlFLRpN8gkJ8Us2Kk/gPbXzyF0o5OzDlN3dxAn7znxef34xOH5dpU6a2AcU9Jza37VdYBENMbkrudOJ5dexz3vV8IlWqOD29p+1a/VXSdKEec9Nx/154AI979dX30E9Twwt19xQjpfQiSe3ScFTv3PiC+uUZbf44RrimNnBWJB456bSbG76oRcMJVFf0PZD56hCMJgf+VwdDlrHl4Pg1zsH1QlB3aFyJ1WFIiRZiQZAyIGSMAdZQ9a6WzWqHdq3UbXKALmY+BUsghGSCxGjK5xDLE2UIJSDkZBkk18C2ydgsiDaMWDZbTiRuJoibZjuB/qk36vRgdiK7yqV2u3m9Vm96xVbXfNSswOpkrvHfUSgSrIWaPebLUCIMGjZI9yjcBTPxChKSXgxZAppdz4Xka58DLEhFwZlm9EmUCppcJhPnjuQEtxGNy/aJAY8yxFD/6SZ6ZThRhSw8AUJ+y9SP4GE1Vrnqo5+0OfyDQNjsx6uueKpYxzbA2oJKIEL5dj04kYUCJgW15RMyKK7d6LGPjryT6qdalVG8l5iiNT6ikuSeBiOh6WQ++NefEBcZgye8D4iklMN/z1QXRYeEvZZzuW6ndZFtdm9W7nrNZqGa+z76qaJfvUhWQ0g0AhCvNTyDMkCT2VOcq4eqkn276lY3dtFY1QCiWNlWdIKGXVpz7Q2mKwt9CKAa3op4uJqYO+SGAPt7u/Wmkc937V3gzfNvYE5dfSxI93fwGBv7bcSTSrd9rNTqNuZmmmZ8xCiIy/C4LNZuMvEPc4UpPlJ+x/bBMHm7e9jwIrHULRMRWotZT6vNhDjyui6Zp8qYc4tS/eP7/vv7UxBJNwQi0KfFuD7PDi9bn9uym2lvboGWfshdk1sEgoLNjqmuS87GDihJ1C1ZVcMgWImyTBJUc1pb4Mg+KYqF8Jg/yIqF/5CeG6IN4=
mNbSHJUhDFTVpfLj
